share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  2024/07/18 12:41

Moomoo AI 已提取核心訊息

BeiGene announced the appointment of Aaron Rosenberg as Chief Financial Officer, effective July 22, 2024, succeeding Julia Wang. Rosenberg, 48, joins from Merck & Co., where he most recently served as Senior VP and Corporate Treasurer. He will receive a base salary of $620,000 with a 60% target bonus and equity awards valued at $5 million.Julia Wang, the current CFO, will resign effective July 19, 2024, and serve as Senior Advisor until August 31 to assist with the transition. Wang will receive severance benefits including 18 months of base salary ($930,000), target bonus, and accelerated vesting of certain equity awards.BeiGene CEO John V. Oyler highlighted the company's status as a top 15 global oncology innovator by revenue, with plans to have at least 10 new molecular entities this year. The company emphasized its continued focus on scaling its business and reinforcing global leadership in hematology while building franchises in other prevalent cancers.
BeiGene announced the appointment of Aaron Rosenberg as Chief Financial Officer, effective July 22, 2024, succeeding Julia Wang. Rosenberg, 48, joins from Merck & Co., where he most recently served as Senior VP and Corporate Treasurer. He will receive a base salary of $620,000 with a 60% target bonus and equity awards valued at $5 million.Julia Wang, the current CFO, will resign effective July 19, 2024, and serve as Senior Advisor until August 31 to assist with the transition. Wang will receive severance benefits including 18 months of base salary ($930,000), target bonus, and accelerated vesting of certain equity awards.BeiGene CEO John V. Oyler highlighted the company's status as a top 15 global oncology innovator by revenue, with plans to have at least 10 new molecular entities this year. The company emphasized its continued focus on scaling its business and reinforcing global leadership in hematology while building franchises in other prevalent cancers.
百濟神州宣佈任命阿倫·羅森伯格爲財務長,任職將於2024年7月22日生效,接替Julia Wang。48歲的羅森伯格此前在默沙東擔任高級副總裁和公司財務主管。他的基本工資爲620,000美元,目標獎金爲60%,以及價值500萬美元的股權獎勵。現任財務長的Julia Wang將於2024年7月19日辭職,並在8月31日前擔任高級顧問以協助過渡。Wang將獲得包括18個月基本工資(930,000美元)、目標獎金和某些股權獎勵的加速歸屬在內的離職福利。百濟神州首席執行官約翰·V·奧伊勒強調公司在營業收入方面作爲全球前15位腫瘤創新者的地位,並計劃今年推出至少10個新的分子實體。公司強調將繼續專注於擴展其業務,加強在血液學領域的全球領導地位,同時在其他常見癌症中建立業務。
百濟神州宣佈任命阿倫·羅森伯格爲財務長,任職將於2024年7月22日生效,接替Julia Wang。48歲的羅森伯格此前在默沙東擔任高級副總裁和公司財務主管。他的基本工資爲620,000美元,目標獎金爲60%,以及價值500萬美元的股權獎勵。現任財務長的Julia Wang將於2024年7月19日辭職,並在8月31日前擔任高級顧問以協助過渡。Wang將獲得包括18個月基本工資(930,000美元)、目標獎金和某些股權獎勵的加速歸屬在內的離職福利。百濟神州首席執行官約翰·V·奧伊勒強調公司在營業收入方面作爲全球前15位腫瘤創新者的地位,並計劃今年推出至少10個新的分子實體。公司強調將繼續專注於擴展其業務,加強在血液學領域的全球領導地位,同時在其他常見癌症中建立業務。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息